MPT

SEC source: 0001287865-18-000018 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,114,044

SEC source: 0001287865-18-000017 · primary_doc.xml · nonDerivative · entry 2

DAWSON G STEVEN · CIK 0001020944 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Self as Trustee for Dawson Interest Pension Plan

Disclosed balance after: 5,662

SEC source: 0001287865-18-000017 · primary_doc.xml · nonDerivative · entry 1

DAWSON G STEVEN · CIK 0001020944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,572

SEC source: 0001287865-18-000016 · primary_doc.xml · derivative · entry 2

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common stock, par value $0.001 · 6,250 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award is the economic equivalent of one share of the Company's common stock.

F3 · shares: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

F3 · derivative.exercise_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

F3 · derivative.expiration_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-18-000016 · primary_doc.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,843

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000009 · primary_doc.xml · derivative · entry 2

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,109

Underlying: Common stock, par value $0.001 · 159,109 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award is the economic equivalent of one share of the Company's common stock.

F3 · derivative.exercise_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · derivative.exercise_date: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

F3 · derivative.expiration_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · derivative.expiration_date: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-18-000009 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,149,044

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000011 · primary_doc.xml · nonDerivative · entry 1

DAWSON G STEVEN · CIK 0001020944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,234

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000015 · primary_doc.xml · nonDerivative · entry 1

Pitman Elizabeth N · CIK 0001732148 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,774.78

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000014 · primary_doc.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,848

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000013 · primary_doc.xml · nonDerivative · entry 1

SPARKS DANIEL PAUL · CIK 0001619358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,872

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000012 · primary_doc.xml · nonDerivative · entry 1

THOMPSON C REYNOLDS III · CIK 0001188038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,591

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000010 · primary_doc.xml · derivative · entry 2

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,198

Underlying: Common stock, par value $0.001 · 143,198 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award is the economic equivalent of one share of the Company's common stock.

F3 · shares: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · shares: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

F3 · derivative.exercise_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · derivative.exercise_date: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

F3 · derivative.expiration_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · derivative.expiration_date: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-18-000010 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,063,965

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-18-000008 · primary_doc.xml · derivative · entry 2

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,218

Underlying: Common stock, par value $0.001 · 318,218 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award is the economic equivalent of one share of the Company's common stock.

F3 · shares: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · shares: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

F3 · derivative.exercise_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · derivative.exercise_date: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

F3 · derivative.expiration_date: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds pertaining to the Company's return on equity (40%), EBITDA (40%), and completed acquisitions (20%), as defined and set by our compensation committee, over the period from January 1, 2018 through December 31, 2020, with the opportunity to earn up to one third of the award in any one year for performance against the specified measures. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. Furthermore, each of the performance based awards are subject to a modifier, which increases or decreases actual shares earned (both in one year and three years) based on the Company's relative total return to shareholders compared to the SNL Healthcare REIT Index. (continued on footnote 4)

F4 · derivative.expiration_date: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-18-000008 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,916,606

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2021; dividends are paid currently.

SEC source: 0001287865-19-000009 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,382,957

SEC source: 0001287865-18-000007 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,759,620

SEC source: 0001287865-18-000005 · primary_doc.xml · nonDerivative · entry 2

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875,836

SEC source: 0001287865-18-000005 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,192,629

SEC source: 0001287865-18-000003 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,124,051

F1 · shares: Represents the additional number of shares that were earned on 2017 grants based on the achievement of specific performance thresholds as set by our compensation committee for the one-year performance period of 2017.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 87,180 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0001287865-18-000002 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 993,321

F1 · shares: Represents the additional number of shares that were earned on 2017 grants based on the achievement of specific performance thresholds as set by our compensation committee for the one-year performance period of 2017.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 64,695 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0001287865-18-000001 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,365,807

F1 · shares: Represents the additional number of shares that were earned on 2017 grants based on the achievement of specific performance thresholds as set by our compensation committee for the one-year performance period of 2017.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 159,331 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0001287865-17-000020 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 989,192

SEC source: 0001287865-17-000019 · primary_doc.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,343

SEC source: 0001287865-17-000018 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,134,760

SEC source: 0001287865-17-000017 · primary_doc.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,606

SEC source: 0001287865-18-000004 · primary_doc.xml · nonDerivative · entry 4

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,070,551

SEC source: 0001287865-18-000004 · primary_doc.xml · nonDerivative · entry 3

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,551

SEC source: 0001287865-18-000004 · primary_doc.xml · nonDerivative · entry 2

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,086,551

SEC source: 0001287865-17-000015 · primary_doc.xml · nonDerivative · entry 2

HAMNER R STEVEN · CIK 0001067414 · Director · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,194,760

F4 · shares: Shares may be earned based on the achievement of a multi-year cumulative total shareholder return as compared to pre-established returns set by our compensation committee. If the cumulative shareholder return from January 1, 2017 through December 31, 2019 is 27% or greater, then 30% of these shares will be earned ("2019 award"). If the cumulative shareholder return from January 1, 2017 through December 31, 2020 is 36% or greater, then 30% of these shares may be earned ("2020 award"). However, the maximum percentage cumulatively earned in connection with both the 2019 award and the 2020 award shall not exceed 30% of the total award. If the cumulative shareholder return from January 1, 2017 through December 31, 2021 is 45% or greater, then 100% of these shares will be earned less the shares earned with the 2019 award and the 2020 award. (continued on footnote 5)

F5 · shares: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-17-000015 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 952,316

F1 · shares: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds as set by our compensation committee for the one-year performance period of 2017. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. The pre-established performance thresholds for 2017 are as follows: a. Approximately 47% of the target shares may be earned based on the Company's return on equity ("ROE"), as defined by our compensation committee, over the period from January 1, 2017 through December 31, 2017. If the Company's ROE is equal to 12.5% for the one-year period, 50% of these shares will be earned. If the Company's ROE is equal to 13%, 100% of these shares will be earned. If the Company's ROE is greater than or equal to 13.5%, 200% of these shares will be earned. (continued on footnote 2)

F2 · shares: b. Approximately 42% of the target shares may be earned based on the achievement of a one-year total shareholder return as compared to the SNL U.S. REIT Healthcare Index ("Index") over the period from January 1, 2017 through December 31, 2017. If the shareholder return is equal to the Index minus 3% for the one-year period, 50% of these shares will be earned. If the shareholder return is equal to the Index, 100% of these shares will be earned. If the shareholder return is greater than or equal to the Index plus 3%, 200% of these shares will be earned. (continued on footnote 3)

F3 · shares: c. Approximately 11% of the target shares may be earned based on the Company's general and administrative expenses ("G&A") as a percentage of revenue, as defined by our compensation committee, over the period from January 1, 2017 through December 31, 2017. If the Company's G&A as a percentage of revenue is equal to 10% for the one-year period, 50% of these shares will be earned. If the Company's G&A as a percentage of revenue is equal to 9.5%, 100% of these shares will be earned. If the Company's G&A as a percentage of revenue is 9% or less, 200% of these shares will be earned. At the end of the one-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-17-000016 · primary_doc.xml · nonDerivative · entry 2

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,372,197

F4 · shares: Shares may be earned based on the achievement of a multi-year cumulative total shareholder return as compared to pre-established returns set by our compensation committee. If the cumulative shareholder return from January 1, 2017 through December 31, 2019 is 27% or greater, then 30% of these shares will be earned ("2019 award"). If the cumulative shareholder return from January 1, 2017 through December 31, 2020 is 36% or greater, then 30% of these shares may be earned ("2020 award"). However, the maximum percentage cumulatively earned in connection with both the 2019 award and the 2020 award shall not exceed 30% of the total award. If the cumulative shareholder return from January 1, 2017 through December 31, 2021 is 45% or greater, then 100% of these shares will be earned less the shares earned with the 2019 award and the 2020 award. (continued on footnote 5)

F5 · shares: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-17-000016 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,887,309

F1 · shares: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds as set by our compensation committee for the one-year performance period of 2017. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. The pre-established performance thresholds for 2017 are as follows: a. Approximately 47% of the target shares may be earned based on the Company's return on equity ("ROE"), as defined by our compensation committee, over the period from January 1, 2017 through December 31, 2017. If the Company's ROE is equal to 12.5% for the one-year period, 50% of these shares will be earned. If the Company's ROE is equal to 13%, 100% of these shares will be earned. If the Company's ROE is greater than or equal to 13.5%, 200% of these shares will be earned. (continued on footnote 2)

F2 · shares: b. Approximately 42% of the target shares may be earned based on the achievement of a one-year total shareholder return as compared to the SNL U.S. REIT Healthcare Index ("Index") over the period from January 1, 2017 through December 31, 2017. If the shareholder return is equal to the Index minus 3% for the one-year period, 50% of these shares will be earned. If the shareholder return is equal to the Index, 100% of these shares will be earned. If the shareholder return is greater than or equal to the Index plus 3%, 200% of these shares will be earned. (continued on footnote 3)

F3 · shares: c. Approximately 11% of the target shares may be earned based on the Company's general and administrative expenses ("G&A") as a percentage of revenue, as defined by our compensation committee, over the period from January 1, 2017 through December 31, 2017. If the Company's G&A as a percentage of revenue is equal to 10% for the one-year period, 50% of these shares will be earned. If the Company's G&A as a percentage of revenue is equal to 9.5%, 100% of these shares will be earned. If the Company's G&A as a percentage of revenue is 9% or less, 200% of these shares will be earned. At the end of the one-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-17-000014 · primary_doc.xml · nonDerivative · entry 2

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,039,192

F5 · shares: Shares may be earned based on the achievement of a multi-year cumulative total shareholder return as compared to pre-established returns set by our compensation committee. If the cumulative shareholder return from January 1, 2017 through December 31, 2019 is 27% or greater, then 30% of these shares will be earned ("2019 award"). If the cumulative shareholder return from January 1, 2017 through December 31, 2020 is 36% or greater, then 30% of these shares may be earned ("2020 award"). However, the maximum percentage cumulatively earned in connection with both the 2019 award and the 2020 award shall not exceed 30% of the total award. If the cumulative shareholder return from January 1, 2017 through December 31, 2021 is 45% or greater, then 100% of these shares will be earned less the shares earned with the 2019 award and the 2020 award. (continued on footnote 6)

F6 · shares: At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-17-000014 · primary_doc.xml · nonDerivative · entry 1

McLean Emmett E · CIK 0001331446 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 820,993

F2 · shares: Represents the target number of shares that may be earned based on the achievement of specific performance thresholds as set by our compensation committee for the one-year performance period of 2017. However, more or less shares than the target number of shares may be earned based on our performance with the number of shares earned based on achievement of performance between points being interpolated on a linear basis. The pre-established performance thresholds for 2017 are as follows: a. Approximately 47% of the target shares may be earned based on the Company's return on equity ("ROE"), as defined by our compensation committee, over the period from January 1, 2017 through December 31, 2017. If the Company's ROE is equal to 12.5% for the one-year period, 50% of these shares will be earned. If the Company's ROE is equal to 13%, 100% of these shares will be earned. If the Company's ROE is greater than or equal to 13.5%, 200% of these shares will be earned. (continued on footnote 3)

F3 · shares: b. Approximately 42% of the target shares may be earned based on the achievement of a one-year total shareholder return as compared to the SNL U.S. REIT Healthcare Index ("Index") over the period from January 1, 2017 through December 31, 2017. If the shareholder return is equal to the Index minus 3% for the one-year period, 50% of these shares will be earned. If the shareholder return is equal to the Index, 100% of these shares will be earned. If the shareholder return is greater than or equal to the Index plus 3%, 200% of these shares will be earned. (continued on footnote 4)

F4 · shares: c. Approximately 11% of the target shares may be earned based on the Company's general and administrative expenses ("G&A") as a percentage of revenue, as defined by our compensation committee, over the period from January 1, 2017 through December 31, 2017. If the Company's G&A as a percentage of revenue is equal to 10% for the one-year period, 50% of these shares will be earned. If the Company's G&A as a percentage of revenue is equal to 9.5%, 100% of these shares will be earned. If the Company's G&A as a percentage of revenue is 9% or less, 200% of these shares will be earned. At the end of the one-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

F1 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 115,000 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0001287865-17-000013 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875,845

F1 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 135,000 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0001287865-17-000012 · primary_doc.xml · nonDerivative · entry 2

Hanna James Kevin · CIK 0001665881 · VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,343

F2 · shares: Shares will be earned based on the achievement of a three-year cumulative total shareholder return as compared to the SNL U.S. REIT Healthcare Index (Index). If our total shareholder return over the three-year cumulative period is less than the Index minus 3%, then no shares will be earned, whereas if our total shareholder return is greater than the Index plus 3% for the same period, then 100% of these shares will be earned. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

SEC source: 0001287865-17-000012 · primary_doc.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · VP, Controller and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,343

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

SEC source: 0001287865-17-000011 · primary_doc.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,734,368

F1 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 250,000 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0001287865-17-000010 · primary_doc.xml · nonDerivative · entry 1

KELLETT SHERRY A · CIK 0001195186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,880

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

SEC source: 0001287865-17-000009 · primary_doc.xml · nonDerivative · entry 1

Holmes Robert E · CIK 0001331605 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,980

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

SEC source: 0001287865-17-000008 · primary_doc.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,900

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

F2 · balance_after: Includes 16,000 share adjustment to properly state current holdings.

SEC source: 0001287865-17-000007 · primary_doc.xml · nonDerivative · entry 1

THOMPSON C REYNOLDS III · CIK 0001188038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,349

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

SEC source: 0001287865-17-000006 · primary_doc.xml · nonDerivative · entry 1

McKenzie William G · CIK 0001331566 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,452

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

SEC source: 0001287865-17-000005 · primary_doc.xml · nonDerivative · entry 1

DAWSON G STEVEN · CIK 0001020944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,992

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

SEC source: 0001287865-17-000004 · primary_doc.xml · nonDerivative · entry 1

SPARKS DANIEL PAUL · CIK 0001619358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,630

F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2017.

SEC source: 0001287865-18-000004 · primary_doc.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,096,551

SEC source: 0001287865-17-000003 · primary_doc.xml · nonDerivative · entry 1

McKenzie William G · CIK 0001331566 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,189

F1 · shares: This sale was made to the Company at the market price.

SEC source: 0001287865-17-000001 · primary_doc.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · VP, Controller, and CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,343